ɫƵ

Event

Neurogenesis Speaker Series: March Edition

Wednesday, March 25, 2026 16:30to18:30
Montreal Neurological Institute de Grandpre Communications Centre, 3801 rue University, Montreal, QC, H3A 2B4, CA

Come meet HBHL-supported Faculty!

Wednesday, March 25, 2026
4:30–6:30 p.m. (includes a one-hour reception)

Get ready for the third edition of Neurogenesis! Get to know HBHL-supported faculty recruits firsthand, learn about their research, ask questions and network with your peers during the post-event reception.

Each event in this series will feature two HBHL faculty recruits whose research areas provide an interesting contrast or intersection for discussion.

March Speakers:

  • Aparna Suvrathan- "Not all synapses are equal: Diversity and plasticity in the cerebellum"
  • -“Advancing treatment targets for addiction: Mapping the road to recovery”
  • Q&A moderated by HBHL Scientific DirectorAlan Evans


Speakers

Headshot portrait of Aparna suvrathanAparna Suvrathan, PhD

Aparna Suvrathan is an Associate Professor at the Centre for Research in Neuroscience at ɫƵ. She is affiliated with the Department of Neurology and Neurosurgery, the Department of Pediatrics and the Research Institute of the ɫƵ Health Centre. She received her PhD at the National Centre for Biological Sciences, Bangalore, India, where she investigated the role of the amygdala in Fragile X syndrome and in affective disorders. Aparna then did postdoctoral research at Stanford University, where her work described the timing rules for plasticity in the cerebellum. Her lab’s focus is on the mouse cerebellum, where they investigate how synaptic properties and plasticity shape circuit function and behaviour, both in health and in disease.

Headshot portrait of Rachel RabinRachel Rabin, PhD

Rachel Rabin is an Associate Professor in the Department of Psychiatry at ɫƵ and a Researcher at the DouglasResearch Centre.Her research program is dedicated to elucidating the clinical, cognitive and neural consequences of addictive substances, particularly cannabis, with the overarching goal of informing the development of more effective treatments for people with substance use disorders. Herlab takes a multimodal approach, integrating comprehensive clinical and cognitive assessments with neuroimaging (MRI, PET) and biological measures. Using controlled abstinence paradigms, they examine the longitudinal trajectory of SUDs to identify predictors of relapse and map the time-course of recovery. This work not only reveals potential therapeutic targets but also pinpoints optimal intervention windows, with direct implications for improving treatment strategies.

The Neuro logoɫƵ logo

The Neuro (Montreal Neurological Institute-Hospital)is a bilingual academic healthcare institution. We are aɫƵ research and teaching institute; delivering high-quality patient care, as part of the Neuroscience Mission of the ɫƵ Health Centre.We areproud to be a Killam Institution, supported by the Killam Trusts.

Back to top